ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ARRY Array Technologies Inc

12.75
0.81 (6.78%)
27 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Array Technologies Inc NASDAQ:ARRY NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.81 6.78% 12.75 12.21 12.87 13.03 11.91 11.91 4,200,487 01:00:00

Array BioPharma To Present At The 2017 Piper Jaffray Healthcare Conference

22/11/2017 3:00pm

PR Newswire (US)


Array Technologies (NASDAQ:ARRY)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Array Technologies Charts.

BOULDER, Colo., Nov. 22, 2017 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the 2017 Piper Jaffray Healthcare Conference.  The public is welcome to participate in the conference through a webcast on the Array BioPharma website.   

Event: 

Piper Jaffray Healthcare Conference

Presenter: 

Ron Squarer, Chief Executive Officer

Date: 

Wednesday, November 29, 2017

Time: 

9:00 a.m. Eastern Time

Webcast: 

https://event.webcasts.com/starthere.jsp?ei=1171462&tp_key=889917fd39

Array BioPharma. (PRNewsFoto/Array BioPharma Inc.) (PRNewsFoto/)

About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.  Nine registration studies are currently advancing related to seven Array-owned or partnered drugs: binimetinib (MEK162), encorafenib (LGX818), selumetinib (partnered with AstraZeneca), danoprevir (partnered with Roche), ipatasertib (partnered with Genentech), larotrectinib (partnered with Loxo Oncology) and tucatinib (partnered with Cascadian Therapeutics).

CONTACT: 

Tricia Haugeto


Array BioPharma Inc.


303-386-1193


thaugeto@arraybiopharma.com

 

 

View original content with multimedia:http://www.prnewswire.com/news-releases/array-biopharma-to-present-at-the-2017-piper-jaffray-healthcare-conference-300556111.html

SOURCE Array BioPharma Inc.

Copyright 2017 PR Newswire

1 Year Array Technologies Chart

1 Year Array Technologies Chart

1 Month Array Technologies Chart

1 Month Array Technologies Chart

Your Recent History

Delayed Upgrade Clock